Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000950103-21-006233
Filing Date
2021-04-28
Accepted
2021-04-28 16:29:30
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM F-3 dp149731_f3.htm F-3 294038
2 EXHIBIT 4.2 dp149731_ex0402.htm EX-4.2 332103
3 EXHIBIT 4.3 dp149731_ex0403.htm EX-4.3 351743
4 EXHIBIT 5.1 dp149731_ex0501.htm EX-5.1 25291
5 EXHIBIT 5.2 dp149731_ex0502.htm EX-5.2 22071
6 EXHIBIT 23.1 dp149731_ex2301.htm EX-23.1 2473
7 GRAPHIC image_002.jpg GRAPHIC 8419
8 GRAPHIC image_003.jpg GRAPHIC 2414
9 GRAPHIC ex0501_bk.jpg GRAPHIC 2731
10 GRAPHIC ex0501_footer.jpg GRAPHIC 13209
  Complete submission text file 0000950103-21-006233.txt   1066116
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-255576 | Film No.: 21864644
SIC: 2834 Pharmaceutical Preparations